Furthermore, 50 mg/kg WX-037 generated a tumour growth delay in HCT116 colorectal tumour xenograft models, which is consistent with previous unpublished studies using WX-037 and published studies using other pan class I PI3K inhibitors that reported tumour growth delay, or in some cases tumour stasis, with greater sensitivity in PIK3CA mutant or PTEN null cells and tumours [5, 14, 15, 46–51]. Here, PIK3CA is linked to colorectal neoplasm.